Group One Trading’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Group One Trading’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,400	Closed	-$9K	–	8393
2022 Q3	$9K	Sell	14,400 -2,400	-14%	-$3.54K	﹤0.01%	6592
2022 Q2	$41K	Buy	16,800 +6,000	+56%	+$16.7K	﹤0.01%	5739
2022 Q1	$44K	Buy	10,800 +4,000	+59%	+$21.9K	﹤0.01%	6190
2021 Q4	$54K	Sell	6,800 -600	-8%	-$7.03K	﹤0.01%	6278
2021 Q3	$143K	Buy	+7,400	New	+$129K	﹤0.01%	5529

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Group One Trading's PLXP Position: Q2 2023 in Review

Group One Trading sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 5,110 shares — an estimated $665 sold.

Group One Trading first reported a position in PLXP in Q3 2021 and held it in 7 quarters. The position peaked at $1.24M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Group One Trading reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 5,110 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $665.
Group One Trading first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Group One Trading's PLx Pharma Inc. Common Stock position peaked at $1.24M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.